Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.35 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3185083 | 0.87 | — | — | |
| SCHEMBL29779753 | 0.87 | LPAR3 (0.41) | LPAR2LPAR3PKMALDH1A1 | |
| SCHEMBL11490361 | 0.87 | MEN1 (0.33) | LPAR2LPAR3PKMALDH1A1 | |
| SCHEMBL4812026 | 0.83 | — | — | |
| SCHEMBL11496486 | 0.83 | CYP3A4 (0.48) | LPAR2LPAR3ALDH1A1 | |
| SCHEMBL11356044 | 0.83 | ACHE (0.46) | — | |
| SCHEMBL6380953 | 0.80 | — | — | |
| SCHEMBL6381791 | 0.79 | — | — | |
| SCHEMBL4272824 | 0.79 | — | — | |
| SCHEMBL9625572 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117820363-A | Method for preparing L-glufosinate-ammonium by using phosphine reagent | 摩珈(上海)生物科技有限公司 | 2024-04-05 | — | — | CN | claimed |
| US-11820749-B2 | Centrally active and orally bioavailable uncharged bisoxime antidotes for organophosphate poisoning and methods for making and using them | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-11-21 | — | — | US | claimed |
| CN-113169395-B | Electrolyte for lithium air battery and lithium air battery using same | 国立研究开发法人物质·材料研究机构 | 2023-09-29 | — | — | CN | claimed |
| US-20220227724-A1 | CENTRALLY ACTIVE AND ORALLY BIOAVAILABLE UNCHARGED BISOXIME ANTIDOTES FOR ORGANOPHOSPHATE POISONING AND METHODS FOR MAKING AND USING THEM | OAK RIDGE NATIONAL LABORATORY | 2022-07-21 | — | — | US | claimed |
| US-20220045389-A1 | ELECTROLYTE FOR LITHIUM AIR BATTERIES, AND LITHIUM AIR BATTERY USING THE SAME | NATIONAL INSTITUTE FOR MATERIALS SCIENCE (JP) | 2022-02-10 | — | — | US | claimed |
| CN-113169395-A | Electrolyte for lithium-air battery and lithium-air battery using same | 国立研究开发法人物质·材料研究机构 | 2021-07-23 | — | — | CN | claimed |
| US-10913726-B2 | Centrally active and orally bioavailable antidotes for organophosphate exposure and methods for making and using them | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-02-09 | — | — | US | claimed |
| WO-2020237079-A1 | CENTRALLY ACTIVE AND ORALLY BIOAVAILABLE UNCHARGED BISOXIME ANTIDOTES FOR ORGANOPHOSPHATE POISONING AND METHODS FOR MAKING AND USING THEM | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-11-26 | — | — | WO | claimed |
| WO-2020142503-A1 | THERAPEUTIC COMBINATIONS AS ANTIDOTES FOR ORGANOPHOSPHATE EXPOSURE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-07-09 | — | — | WO | claimed |
| US-20190119237-A1 | CENTRALLY ACTIVE AND ORALLY BIOAVAILABLE ANTIDOTES FOR ORGANOPHOSPHATE EXPOSURE AND METHODS FOR MAKING AND USING THEM | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2019-04-25 | — | — | US | claimed |
| US-10060887-B2 | Field sampling kit and methods for collecting and detecting alkyl methylphosphonic acids | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 2018-08-28 | — | — | US | claimed |
| EP-2956451-A1 | CENTRALLY ACTIVE AND ORALLY BIOAVAILABLE ANTIDOTES FOR ORGANOPHOSPHATE EXPOSURE AND METHODS FOR MAKING AND USING THEM | The Regents of the University of California (US) | 2015-12-23 | — | — | EP | claimed |
| US-20150361060-A1 | CENTRALLY ACTIVE AND ORALLY BIOAVAILABLE ANTIDOTES FOR ORGANOPHOSPHATE EXPOSURE AND METHODS FOR MAKING AND USING THEM | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-12-17 | — | — | US | claimed |
| WO-2014127315-A1 | CENTRALLY ACTIVE AND ORALLY BIOAVAILABLE ANTIDOTES FOR ORGANOPHOSPHATE EXPOSURE AND METHODS FOR MAKING AND USING THEM | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-08-21 | — | — | WO | claimed |
| US-20140113380-A1 | FIELD SAMPLING KIT AND METHODS FOR COLLECTING AND DETECTING ALKYL METHYLPHOSPHONIC ACIDS | U.S. ARMY MEDICAL RESEARCH AND MATERIEL COMMAND (US) | 2014-04-24 | — | — | US | claimed |
| WO-2012138384-A1 | FIELD SAMPLING KIT AND METHODS FOR COLLECTING AND DETECTING ALKYL METHYLPHOSPHONIC ACIDS | U.S. ARMY MEDICAL RESEARCH AND MATERIEL COMMAND (US) | 2012-10-11 | — | — | WO | claimed |
| US-4108746-A | IRRADIATING TO INDUCE OXIDATION | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1978-08-22 | — | — | US | claimed |
| US-12100809-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-24 | — | — | US | disclosed |
| US-3972960-A | Heat-stable polyimide resin modified by unsaturated polyester | RHONE-POULENC S.A. (FR) | 1976-08-03 | — | — | US | disclosed |
| US-3970714-A | Heat-stable polyimide resin modified by unsaturated polyester | RHONE-POULENC S.A. (FR) | 1976-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220227724-A1 | CENTRALLY ACTIVE AND ORALLY BIOAVAILABLE UNCHARGED BISOXIME ANTIDOTES FOR ORGANOPHOSPHATE POISONING AND METHODS FOR MAKING AND USING THEM | BCHE, ACHE, FHIT | LPAR2 3176/4885LPAR3 2810/4885PKM 1214/4885 |
| US-20150361060-A1 | CENTRALLY ACTIVE AND ORALLY BIOAVAILABLE ANTIDOTES FOR ORGANOPHOSPHATE EXPOSURE AND METHODS FOR MAKING AND USING THEM | ACHE, BCHE, IDE | LPAR2 2940/4885LPAR3 2357/4885PKM 2542/4885 |
| US-11820749-B2 | Centrally active and orally bioavailable uncharged bisoxime antidotes for organophosphate poisoning and methods for making and using them | BCHE, ACHE, FHIT | LPAR2 3176/4885LPAR3 2810/4885PKM 1214/4885 |
| US-20190119237-A1 | CENTRALLY ACTIVE AND ORALLY BIOAVAILABLE ANTIDOTES FOR ORGANOPHOSPHATE EXPOSURE AND METHODS FOR MAKING AND USING THEM | ACHE, BCHE, IDE | LPAR2 2940/4885LPAR3 2357/4885PKM 2542/4885 |
| US-10913726-B2 | Centrally active and orally bioavailable antidotes for organophosphate exposure and methods for making and using them | ACHE, BCHE, IDE | LPAR2 2940/4885LPAR3 2357/4885PKM 2542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.